Document is current
Any future updates will be listed below
-
Authors
de Oliveira Souza, Natália Vasconcellos
Sharma, Rohan
de Toledo, Otavio Frederico
Marques, Ingrid Pereira
Gutierrez-Aguirre, Salvador F.
Montserrat, Lara-Velazquez
Sauvageau, Eric
Neeraj, Naval
Aghaebrahim, Amin
Chaddad Neto, Feres
Hanel, Ricardo A.
Silva, Gisele Sampaio
Freeman, William David
-
Funding
Funding for this research was provided by:
Bee Foundation
- License Information
-
More Information
Article History
Received: 5 October 2025
Accepted: 27 December 2025
First Online: 31 December 2025
Declarations
:
: The authors declare no competing interests.
: - Dr. Natália Souza received a research Health Equity Grant from the Bee Foundation;- Dr. Hanel has grants or contracts from NIH, Interline Endowment, Microvention, Stryker, CNX, and he is a consultant for Balt, Cerenovus, Medtronic, Microvention, Rapid Medical, Phenox, Q’Apel, and Stryker. He is also in the board of eLum, Three Rivers, Shape Medical, and Corindus.- Dr. Silva has grants or contracts from the Brazilian Ministry of Health, OPTIMAL trial, Resilient Extend IV trial, and Biogen Charm trial. She is also a consultant for Boehringer Ingelheim and Astrazeneca.- Dr. Freeman has royalties and license over Cambridge, Oxford, UpToDate.
: This material was accepted as a mini-podium presentation at the Congress of Neurological Surgeons (CNS), Los Angeles, United States, 2025.
